XORTX Therapeutics Inc. Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Accounts payable and accrued liabilities (Tables)

Accounts payable and accrued liabilities (Tables)

12 Months Ended

Dec. 31, 2021

Accounts Payable And Accrued Liabilities

Schedule of accounts payable and accrued liabilities

		December 31 2021				December 31 2020
			$				$
Trade payables			410,701				389,982
Accrued liabilities			290,298				644,231
Total			700,999				1,034,213